Eyenovia Inc (EYEN) Misses Q2 EPS by 1c

Go back to Eyenovia Inc (EYEN) Misses Q2 EPS by 1c

Eyenovia Reports Second Quarter 2022 Financial Results

August 10, 2022 4:05 PM EDT

Announced appointment of Michael Rowe as Chief Executive Officer and Board member

Mydcombi NDA resubmission on track for the fourth quarter of 2022

Phase 3 VISION-2 study evaluating MicroLine as an on-demand treatment for improving near vision (presbyopia) progressing as planned; topline data expected in the third quarter of 2022

Company to host conference call and webcast today, August 10, at 4:30 pm ET

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) --... More